1st Quarter - Report

PRIME POLICY GROUP for KEDRION BIOPHARMA

Period 1st Quarter 2026 Filed Apr 8, 2026 Signed by Jacob Beaver

Official filing
Firm
PRIME POLICY GROUP
Client
KEDRION BIOPHARMA
Income
$140,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Pharmaceutical tariffs

Foreign entity interest: Pharmaceutical tariffs

LobbyistCovered position, as disclosed
CASIE ELIZABETH DAUGHERTY —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.